Price $2.28 |
Market Cap
32.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.57
|
P/S
-
|
Dividend %
-
|
|
P/CF
3.6
|
P/FCF
-
|
Op. Cash Flow
-16.8K
|
FCF
-1.3
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-32.60%
|
ROI
-
|
|
ROA
-30.60%
|
EPS Growth
41.90%
|
Current Ratio
14.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Emmaus Life Sciences Inc (EMMA) | $1.55 | - | - | 71.5M | Strong Buy |
| Generex Biotechnology Corporat (GNBT) | $0.08 | - | - | 10.7M | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.23 | - | - | 7.3M | Strong Buy |
| Magellan Health Inc (MGLN) | $94.44 | - | - | 2.49B | Strong Buy |
| Surgalign Holdings Inc (SRGA) | $0.73 | - | - | 105.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
